Zydus Lifesciences Limited has received final approval for Levothyroxine Sodium for injection, 100 mcg/vial, 200 mcg/vial, and 500 mcg/vial from the United States Food and Drug Administration (USFDA), as per an exchange filing.
Levothyroxine Sodium Injection is indicated for the treatment of myxedema coma.
The drug will be manufactured at the group’s injectable manufacturing facility at Jarod, near Vadodara (India).
The group now has 354 approvals and has so far filed over 440 ANDAs since the commencement of the filing process in FY 2003-04.
Mumbai Crime: 18-Year-Old Man Stabbed To Death Near LTT In Revenge Attack After Slapping Men For Lewd Behaviour In Rickshaw
Mumbai News: Alert Railway Police Save Man From Falling Under Moving Train At King's Circle Station
1993 Mumbai Bomb Blast Case: Abu Salem Must Serve 25 Years Of Actual Imprisonment Before Release, Maharashtra Govt Tells Bombay HC
'No Blanket Ban On Indian Seafarers With Foreign CoCs, Only Verification Mandated': DG Shipping Tells Bombay HC
